Tulbah, A. S. (2025) “Formulation and in vitro characterization of inhalable dasatinib-nanoemulsion as a treatment potential against A549 and Calu-3 lung cancer cells”, International Journal of Health Sciences, 19(1), pp. 4–14. Available at: https://pub.qu.edu.sa/index.php/journal/article/view/8643 (Accessed: 12 January 2025).